Shire

Shire enables people with life-altering conditions to lead better lives. Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We provide treatments in Rare Diseases, Neuroscience, Gastrointestinal, Internal Medicine and Regenerative Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas.

Our Rare Diseases business unit is solely focused on researching, developing and marketing novel products and services that profoundly enhance the quality of life of patients suffering from rare diseases such as Hunter syndrome, Fabry disease, Gaucher disease, Sanfilippo Syndrome, metachromatic leukodystrophy and Hereditary Angioedema (HAE).